If I he fda can approve camzyos in a restricted program for an unmet need they should not have a problem approving eftilagimod for head and neck cancers with low pd1
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $357.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.8¢ | 24.0¢ | $66.1K | 270.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25060 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 213853 | 12 |
View Market Depth
| Last trade - 11.01am 18/06/2025 (20 minute delay) ? |
| IMM (ASX) Chart |